lentiGuide-Crimson Citations (8)

Originally described in: BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, Chen DD, Schupp PG, Vinjamur DS, Garcia SP, Luc S, Kurita R, Nakamura Y, Fujiwara Y, Maeda T, Yuan GC, Zhang F, Orkin SH, Bauer DE Nature. 2015 Sep 16. doi: 10.1038/nature15521. PubMed Journal

---

Articles Citing lentiGuide-Crimson

Articles
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis. Kelly MJ, So J, Rogers AJ, Gregory G, Li J, Zethoven M, Gearhart MD, Bardwell VJ, Johnstone RW, Vervoort SJ, Kats LM. Nat Commun. 2019 Mar 22;10(1):1347. doi: 10.1038/s41467-019-09250-6. PubMed
Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion. Freeman AJ, Vervoort SJ, Ramsbottom KM, Kelly MJ, Michie J, Pijpers L, Johnstone RW, Kearney CJ, Oliaro J. Cell Rep. 2019 Sep 10;28(11):2784-2794.e5. doi: 10.1016/j.celrep.2019.08.017. PubMed
Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells. Ghasemi R, Struthers H, Wilson ER, Spencer DH. Leukemia. 2021 Feb;35(2):404-416. doi: 10.1038/s41375-020-0856-3. Epub 2020 May 12. PubMed
Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL. Sasaki K, Yamauchi T, Semba Y, Nogami J, Imanaga H, Terasaki T, Nakao F, Akahane K, Inukai T, Verhoeyen E, Akashi K, Maeda T. Blood. 2022 Feb 3;139(5):748-760. doi: 10.1182/blood.2021012976. PubMed
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. So J, Lewis AC, Smith LK, Stanley K, Franich R, Yoannidis D, Pijpers L, Dominguez P, Hogg SJ, Vervoort SJ, Brown FC, Johnstone RW, McDonald G, Ulanet DB, Murtie J, Gruber E, Kats LM. EMBO Mol Med. 2022 Jul 7;14(7):e15203. doi: 10.15252/emmm.202115203. Epub 2022 May 6. PubMed
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model. Yamaguchi K, Yoshihiro T, Ariyama H, Ito M, Nakano M, Semba Y, Nogami J, Tsuchihashi K, Yamauchi T, Ueno S, Isobe T, Shindo K, Moriyama T, Ohuchida K, Nakamura M, Nagao Y, Ikeda T, Hashizume M, Konomi H, Torisu T, Kitazono T, Kanayama T, Tomita H, Oda Y, Kusaba H, Maeda T, Akashi K, Baba E. Gastric Cancer. 2022 Sep;25(5):862-878. doi: 10.1007/s10120-022-01307-8. Epub 2022 Jun 4. PubMed
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses. Chan KL, Gomez J, Cardinez C, Kumari N, Sparbier CE, Lam EYN, Yeung MM, Garciaz S, Kuzich JA, Ong DM, Brown FC, Chan YC, Vassiliadis D, Wainwright EN, Motazedian A, Gillespie A, Fennell KA, Lai J, House IG, Macpherson L, Ang CS, Dawson SJ, Beavis PA, Wei AH, Burr ML, Dawson MA. Cancer Cell. 2022 Oct 10;40(10):1190-1206.e9. doi: 10.1016/j.ccell.2022.09.007. Epub 2022 Sep 29. PubMed
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia. Lewis AC, Gruber E, Franich R, Armstrong J, Kelly MJ, Opazo CM, Low YC, Flippe L, Wijanarko K, Rowe CL, Mawal CH, Birrell A, So J, Vaidyanathan S, Ting K, Semcesen LN, Last K, Ang CS, Pomilio G, Brown FC, Wei AH, Powell JA, Ng ES, Frazier AE, McArthur K, Lalaoui N, Stroud DA, Brown KK, Johnstone RW, Kats LM. Cell. 2026 Jan 8;189(1):215-232.e24. doi: 10.1016/j.cell.2025.10.028. Epub 2025 Nov 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.